• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪布鲁氏菌2型疫苗对公羊感染绵羊布鲁氏菌的效力。

Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams.

作者信息

Blasco J M, Marín C, Jiménez de Bagüés M P, Barberán M

机构信息

Servicio de Investigación Agraria, Diputación General de Aragón, Zaragoza, Spain.

出版信息

Vaccine. 1993 Oct;11(13):1291-4. doi: 10.1016/0264-410x(93)90097-h.

DOI:10.1016/0264-410x(93)90097-h
PMID:8296481
Abstract

The protective efficacy against Brucella ovis of live vaccine Brucella suis strain 2 (S2) and Brucella melitensis strain Rev 1 has been evaluated in rams. Fourteen 4-month-old Brucella-free Aragonesa rams were vaccinated conjunctivally with 2 x 10(9) c.f.u. S2. Sixteen rams of the same breed, condition and age were conjunctivally vaccinated the same day with 1.6 x 10(9) Rev 1. Thirteen rams were unvaccinated controls. Eight months after vaccination all rams were challenged with 6 x 10(9) c.f.u. B. ovis and slaughtered 2 months thereafter for bacteriological and pathological studies. The percentage of infection in the group vaccinated with Rev 1 (43.7%) was significantly lower (p < 0.05) than that of the S2-vaccinated animals (78.6%) and unvaccinated controls (84.6%). No significant differences were found when comparing the percentages of infection corresponding to S2-vaccinated and control groups. The degree of infection (percentage of necropsy samples infected) was significantly lower in Rev 1-vaccinated (13%) than in S2-vaccinated (36.9%) or control groups (47.4%) (p < 0.001). However, no significant differences were found when comparing S2-vaccinated and control groups.

摘要

已对公羊评估了猪布鲁氏菌2号菌株(S2)活疫苗和羊布鲁氏菌Rev 1菌株对绵羊布鲁氏菌的保护效力。14只4月龄无布鲁氏菌的阿拉贡公羊通过结膜接种2×10⁹ c.f.u.的S2进行疫苗接种。16只相同品种、状况和年龄的公羊于同一天通过结膜接种1.6×10⁹的Rev 1。13只公羊作为未接种疫苗的对照。接种疫苗8个月后,所有公羊用6×10⁹ c.f.u.的绵羊布鲁氏菌进行攻毒,并在2个月后宰杀以进行细菌学和病理学研究。接种Rev 1的组(43.7%)的感染率显著低于接种S2的动物组(78.6%)和未接种疫苗的对照组(84.6%)(p<0.05)。比较接种S2的组和对照组的感染率时未发现显著差异。接种Rev 1的组(13%)的感染程度(尸检样本感染百分比)显著低于接种S2的组(36.9%)或对照组(47.4%)(p<0.001)。然而,比较接种S2的组和对照组时未发现显著差异。

相似文献

1
Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams.猪布鲁氏菌2型疫苗对公羊感染绵羊布鲁氏菌的效力。
Vaccine. 1993 Oct;11(13):1291-4. doi: 10.1016/0264-410x(93)90097-h.
2
The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams.布鲁氏菌流产RB51疫苗不能对公羊提供针对绵羊布鲁氏菌的保护。
Vaccine. 1995 Feb;13(3):301-4. doi: 10.1016/0264-410x(95)93317-3.
3
Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes.猪布鲁氏菌2号菌株和羊布鲁氏菌Rev. 1活疫苗对妊娠母羊羊布鲁氏菌实验性感染的疗效比较。
Vaccine. 1995 Feb;13(2):191-6. doi: 10.1016/0264-410x(95)93135-v.
4
Immunization with Brucella melitensis Rev 1 against Brucella ovis infection of rams.用布鲁氏菌羊种1号菌苗(Rev 1)免疫公羊以预防绵羊布鲁氏菌感染。
Vet Microbiol. 1987 Sep;14(4):381-92. doi: 10.1016/0378-1135(87)90029-0.
5
Efficacy of Brucella melitensis Rev. 1 vaccine against Brucella ovis infection in rams.羊种布鲁氏菌Rev. 1疫苗对公羊感染绵羊布鲁氏菌的效力。
Ann Rech Vet. 1982;13(2):185-90.
6
Comparison of subcutaneous and conjunctival routes of Rev 1 vaccination for the prophylaxis of Brucella ovis infection in rams.皮下和结膜途径接种Rev 1疫苗预防公羊绵羊布鲁氏菌感染的比较。
Res Vet Sci. 1990 Mar;48(2):209-15.
7
Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.针对公羊布鲁氏菌病的全细胞疫苗和亚细胞疫苗评估。
Vet Immunol Immunopathol. 1993 Aug;37(3-4):257-70. doi: 10.1016/0165-2427(93)90198-d.
8
Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.评价绵羊附睾分枝杆菌感染的微粒非细胞疫苗。
Vaccine. 2010 Apr 9;28(17):3038-46. doi: 10.1016/j.vaccine.2009.10.073. Epub 2009 Nov 1.
9
Effectivity of Rev 1 vaccine in rams against brucella ovis infection.Rev 1疫苗对公羊抗绵羊布鲁氏菌感染的有效性。
J S Afr Vet Assoc. 1975 Dec;46(4):349-51.
10
Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine.用马尔他布鲁氏菌Rev 1疫苗免疫的公羊中,针对绵羊布鲁氏菌感染的保护性反应可能相关因素的特征分析。
Vaccine. 2009 May 18;27(23):3039-44. doi: 10.1016/j.vaccine.2009.03.046. Epub 2009 Apr 7.

引用本文的文献

1
Efficacy of Vaccines in Sheep: A Systematic Review and Meta-Analysis.绵羊疫苗的疗效:系统评价与荟萃分析
Transbound Emerg Dis. 2024 Jul 26;2024:5524768. doi: 10.1155/2024/5524768. eCollection 2024.
2
Facing the Human and Animal Brucellosis Conundrums: The Forgotten Lessons.面对人类和动物布鲁氏菌病难题:被遗忘的教训
Microorganisms. 2022 Apr 30;10(5):942. doi: 10.3390/microorganisms10050942.
3
Development of attenuated live vaccine candidates against swine brucellosis in a non-zoonotic B. suis biovar 2 background.针对非动物源性 2 型布氏菌生物型的猪布鲁氏菌病,研制减毒活疫苗候选株。
Vet Res. 2020 Jul 23;51(1):92. doi: 10.1186/s13567-020-00815-8.
4
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with and .在《动物卫生法》(欧盟第2016/429号法规)框架内对动物疾病进行列名和分类的评估:感染……和……
EFSA J. 2017 Jul 20;15(7):e04889. doi: 10.2903/j.efsa.2017.4889. eCollection 2017 Jul.
5
The BtaF Adhesin Is Necessary for Full Virulence During Respiratory Infection by and Is a Novel Immunogen for Nasal Vaccination Against Infection.BtaF 黏附素是 引起呼吸道感染时完全毒力所必需的,也是针对 感染鼻腔疫苗接种的新型免疫原。
Front Immunol. 2019 Jul 26;10:1775. doi: 10.3389/fimmu.2019.01775. eCollection 2019.
6
Comparative genomic analysis between newly sequenced Brucella suis Vaccine Strain S2 and the Virulent Brucella suis Strain 1330.新测序的猪布鲁氏菌疫苗株S2与猪布鲁氏菌强毒株1330之间的比较基因组分析。
BMC Genomics. 2016 Sep 20;17(1):741. doi: 10.1186/s12864-016-3076-5.
7
Bioluminescence Imaging of Colonization and Clearance Dynamics of Brucella Suis Vaccine Strain S2 in Mice and Guinea Pigs.猪布鲁氏菌疫苗株S2在小鼠和豚鼠体内定植与清除动态的生物发光成像研究
Mol Imaging Biol. 2016 Aug;18(4):519-26. doi: 10.1007/s11307-015-0925-6.
8
Retrospective and prospective perspectives on zoonotic brucellosis.人畜共患布鲁氏菌病的回顾性与前瞻性视角
Front Microbiol. 2014 May 13;5:213. doi: 10.3389/fmicb.2014.00213. eCollection 2014.
9
Progress in vaccine development.疫苗研发进展。
Front Biol (Beijing). 2013 Feb 1;8(1):60-77. doi: 10.1007/s11515-012-1196-0.
10
Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.布鲁氏菌病中的分子宿主-病原体相互作用:对小鼠和人类疫苗开发的当前认识及未来方法
Clin Microbiol Rev. 2003 Jan;16(1):65-78. doi: 10.1128/CMR.16.1.65-78.2003.